In addition, a recent meta-analysis of seven human NAFLD genetic data sets identified GNMT downregulation in a genetic signature of NAFLD progression, while MAT1A was not acknowledged [10]. This evidence concerns the gene MAT1A and metabolic dysfunction-associated steatotic liver disease.